Recently, Apollo Hospitals Enterprise (AHEL) announced a re-organization during the premotive sale of the identified business undertaking including AHEL's back-end offline pharmacy business (excluding hospital-based pharmacies), AHEL's digital healthcare platform Apollo 24/7, AHEL's investment in retail pharmacy business (Apollo Medicals), the "Apollo 24/7" brand, the "Apollo Pharmacy" brand, and private label brands into AHEL's 100 percent subsidiary Apollo HealthCo (AHL).

Apollo HealthCo represents Apollo Group's transformational journey towards creating India's largest omnichannel healthcare platform. This platform will combine the strengths of Apollo Group's offline healthcare leadership with Apollo Group's new-age digital offerings to address all healthcare consumer needs.

This proposed reorganization will set the platform for tapping new pools of investor capital that will enable rapid scale-up of the digital healthcare platform.

 At the time of capital raise, AHL valuation will reflect current and future growth potential. Post external capital raise at AHL, AHEL is expected to retain a dominant majority shareholding in AHL and a slump sale consideration of INR 1,210 crores will be received by AHEL.

This is the next step in the already announced multi-year unlocking of value for AHEL shareholders and paves the way to fuel the growth of India's largest omni-channel healthcare platform.